PathoQuest, a life sciences spin-out of the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA), has raised €3.8m ($5m) in series B private equity (PE) funding.
Participants in the round were PE firms IDInvest Partners, Kurma Life Science Partners, and Aurinvest.
The funding will be used to fuel Paris-based PathoQuest’s trials and technology development. The firm is working on next-generation infectious disease diagnostic arrays, which it plans to launch in 2015.
In 2020, Stellenbosch University launched Africa's first-ever university venture fund focused on spinouts — here's how it's reshaping the country.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
